Chat with this insight
Save time and jump to the most important pieces.
Recent Analyst Ratings for $EHAB
Date | Price Target | Rating | Analyst |
---|---|---|---|
12/9/2024 | $8.25 → $9.50 | Hold → Buy | Jefferies |
5/14/2024 | $8.50 | Underperform → Market Perform | Leerink Partners |
5/9/2024 | $14.00 → $8.75 | Buy → Hold | Jefferies |
3/7/2024 | $9.50 | Sell → Neutral | UBS |
12/12/2023 | $12.00 | Market Perform | TD Cowen |
6/20/2023 | $10.00 | Underperform | SVB Securities |
3/16/2023 | $15.00 | Neutral | Goldman |
12/13/2022 | $18.00 | Market Perform | CJS Securities |
Enhabit Home Health & Hospice Achieves Level 2 Recognition as an Age-Friendly Health System — Committed to Care Excellence
Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice provider, today announced that it has achieved Level 2 recognition as an Age-Friendly Health System – Committed to Care Excellence by the Institute for Healthcare Improvement (IHI). This prestigious recognition honors Enhabit's dedication to providing high-quality, evidence-based care to older adults, ensuring their unique needs and preferences are consistently met. The Age-Friendly Health Systems initiative, led by The John A. Hartford Foundation and IHI in partnership with the American Hospital Association (AHA) and the Catholic Health Association of the United States (CHA), focuses on the 4Ms framework: What Matters, Medicatio
Enhabit Reports Fourth Quarter Results and Issues Full-Year 2025 Guidance
Company to host a conference call tomorrow, March 6, 2025, at 10 a.m. EST Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended Dec. 31, 2024. "Enhabit is exiting 2024 having executed specific strategies that set us up for long-term growth in both our home health and hospice segments," said Barb Jacobsmeyer, president and chief executive officer of Enhabit. "In our home health segment, fourth quarter Medicare census continued to stabilize, and with the renegotiation of a large national contract complete, we will be well positioned as a full-service provider to our referral sources. The hospice segm
Enhabit Home Health & Hospice to Nominate Stephan Rodgers to Board of Directors
Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice provider, today announced its board of directors will nominate Stephan Rodgers to stand for election as a director of the company at Enhabit's 2025 annual meeting of stockholders. Chairman of the Board Jeff Bolton said, "We look forward to Steve joining us as a director and we believe our stockholders will agree that he brings strong, relevant industry expertise to our board. Steve's 25 years of executive-level experience in building companies of scale, including in the home health and hospice industry, will give him a unique perspective as our board oversees management's execution of our long-term strategies." Rodgers previou
Enhabit Inc. upgraded by Jefferies with a new price target
Jefferies upgraded Enhabit Inc. from Hold to Buy and set a new price target of $9.50 from $8.25 previously
Enhabit Inc. upgraded by Leerink Partners with a new price target
Leerink Partners upgraded Enhabit Inc. from Underperform to Market Perform and set a new price target of $8.50
Enhabit Inc. downgraded by Jefferies with a new price target
Jefferies downgraded Enhabit Inc. from Buy to Hold and set a new price target of $8.75 from $14.00 previously
Director Bolton Jeffrey bought $34,760 worth of shares (4,000 units at $8.69), increasing direct ownership by 4% to 98,144 units (SEC Form 4)
4 - Enhabit, Inc. (0001803737) (Issuer)
Director Mcguigan Stuart M bought $132,150 worth of shares (15,000 units at $8.81), increasing direct ownership by 47% to 46,810 units (SEC Form 4)
4 - Enhabit, Inc. (0001803737) (Issuer)
Director Bolton Jeffrey bought $77,177 worth of shares (10,000 units at $7.72), increasing direct ownership by 12% to 94,144 units (SEC Form 4)
4 - Enhabit, Inc. (0001803737) (Issuer)
Chief Human Resources Officer Marion Tanya Renee was granted 25,095 shares and covered exercise/tax liability with 2,604 shares, increasing direct ownership by 61% to 59,634 units (SEC Form 4)
4 - Enhabit, Inc. (0001803737) (Issuer)
EVP of Home Health Operations Jolley Julie Diane was granted 32,949 shares and covered exercise/tax liability with 2,924 shares, increasing direct ownership by 48% to 92,259 units (SEC Form 4)
4 - Enhabit, Inc. (0001803737) (Issuer)
EVP Clinical Excel. & Strategy Langham Ronald Leroy Jr was granted 7,092 shares and covered exercise/tax liability with 2,377 shares, increasing direct ownership by 9% to 56,164 units (SEC Form 4)
4 - Enhabit, Inc. (0001803737) (Issuer)
SEC Form 10-K filed by Enhabit Inc.
10-K - Enhabit, Inc. (0001803737) (Filer)
Enhabit Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Enhabit, Inc. (0001803737) (Filer)
Enhabit Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Enhabit, Inc. (0001803737) (Filer)
Delaware Court of Chancery Awards Damages and Other Relief to Encompass Health and Enhabit for Misconduct by April Anthony, Other Former Officers, and Private Equity Firms Vistria Group and Nautic Partners
On Monday, Encompass Health and Enhabit won their lawsuit in the Delaware Court of Chancery related to breaches of fiduciary duty by April Anthony, Luke James, and Chris Walker while they served as the senior officers at Encompass Health's former home health and hospice division, which is now Enhabit. The Court awarded judgment against private equity firms Vistria Group and Nautic Partners and the home health and hospice business now known as VitalCaring Group for aiding and abetting "the egregious breaches of the duty of loyalty" by Anthony, James, and Walker. The case was the subject of a 7-day trial in December 2023. After considering "the damning record presented at trial," the Court
Enhabit Home Health & Hospice Appoints Ryan Solomon as Chief Financial Officer
Seasoned Industry Executive Brings Significant Financial Operations Expertise and Track Record of Driving Growth and Value Creation Enhabit, Inc. (NYSE:EHAB), ("Enhabit"), a leading home health and hospice provider, today announced the appointment of Ryan Solomon as its next chief financial officer (CFO), effective Dec. 9, 2024. Mr. Solomon's appointment follows the previously announced transition of Crissy Carlisle, CFO. Mr. Solomon brings to Enhabit over 20 years of corporate strategy and finance experience, including eight years as CFO in the home health and hospice space and other industries. Mr. Solomon previously served as CFO of AccentCare, where he was responsible for financial pl
American Water Appoints New Independent Member to the Board of Directors
American Water Works Company, Inc. (NYSE:AWK) announced today that Stuart M. McGuigan has been appointed as an independent member of the company's board of directors, effective Oct. 29, 2024. "American Water is pleased to have Stuart join our board of directors," said Karl Kurz, Board Chair of American Water. "Stuart has more than 38 years of extensive experience in information technology and management including serving as the Chief Information Officer for national and global public companies, as well as a government agency. He will further strengthen our board, and we look forward to working with him." "We are honored to have Stuart become part of American Water's board," said M. Susan
Enhabit Reports Fourth Quarter Results and Issues Full-Year 2025 Guidance
Company to host a conference call tomorrow, March 6, 2025, at 10 a.m. EST Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended Dec. 31, 2024. "Enhabit is exiting 2024 having executed specific strategies that set us up for long-term growth in both our home health and hospice segments," said Barb Jacobsmeyer, president and chief executive officer of Enhabit. "In our home health segment, fourth quarter Medicare census continued to stabilize, and with the renegotiation of a large national contract complete, we will be well positioned as a full-service provider to our referral sources. The hospice segm
Enhabit Home Health & Hospice Announces Date of 2024 Fourth Quarter Earnings Call
Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it will report its results for the fourth quarter ended Dec. 31, 2024, on March 5, 2025, and host a webcast and conference call on March 6, 2025. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. March 6, 2025 10 a.m. EDT Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Internet website: https://events.q4inc.com/attendee/519715442 A link to the webcast of the conference call and online replay can be found on Enhabit's investor website. About Enhabit Home Health & Hospice
Enhabit Reports Third Quarter 2024 Financial Results
Company to host a conference call tomorrow, November 7, 2024, at 10 a.m. EST Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the third quarter ended September 30, 2024. "Our continued progress in our strategies during the third quarter resulted in Adjusted EBITDA growth year over year and strong free cash flow generation that led to further debt reduction," said Enhabit's President and Chief Executive Officer Barb Jacobsmeyer. "The payor innovation strategy continues to foster Medicare Advantage growth in our home health segment, and average daily census continues to grow in our hospice segment." QUARTERLY PERFORMAN
SEC Form SC 13G filed by Enhabit Inc.
SC 13G - Enhabit, Inc. (0001803737) (Subject)
Amendment: SEC Form SC 13G/A filed by Enhabit Inc.
SC 13G/A - Enhabit, Inc. (0001803737) (Subject)
SEC Form SC 13G/A filed by Enhabit Inc. (Amendment)
SC 13G/A - Enhabit, Inc. (0001803737) (Subject)